Patent 7468371 was granted and assigned to Abbott on December, 2008 by the United States Patent and Trademark Office.
Compounds of the present invention are useful for inhibiting protein tyrosine kinases. Also disclosed are methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.